Parkinsonism induced by chronic manganese intoxication - An experience in Taiwan

Chang Gung Medical Journal

Volumn 30, Issue 5, 2007, Pages 385-395

  Huang, Chin Chang ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Manganism; Neuroimages; Neuropathology; Parkinsonism (PD); Welding

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CONTRAST MEDIUM; DOPAMINE TRANSPORTER; LEVODOPA; MANGANESE; PLACEBO; SELEGILINE; TRIHEXYPHENIDYL;

CLINICAL TRIAL; DISEASE COURSE; FOLLOW UP; HUMAN; INTOXICATION; MANGANISM; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL EXPOSURE; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TAIWAN; WELDING FUME;

ANIMALS; BRAIN; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MANGANESE POISONING; OCCUPATIONAL EXPOSURE; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; WELDING;

EID: 36549015810     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Mena I. Manganese poisoning. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology, vol. 36. Amsterdam: Elsevier/North Hollard, 1979:217-37.
2. Feldman RG. Manganese. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology, vol. 64. Intoxication of the Nervous System. Pt 1. de. Wolff FA, ed. Amsterdam: Elsevier Science BV, 1994:303-22.
3. Chu NS, Huang CC, Calne DB. Manganese. In: Spencer PS, Schaumburg HH, eds. Clinical and Experimental Neurotoxicology. 2nd ed. Tokyo: Springer Science & Business Media, 2000:752-5.
4. Chu NS, Hochberg FH, Calne DB, Olanow CW. Neurotoxicology of manganese. In: Chang LW, Dyer RS, eds. Handbook of Neurotoxicology. 1st ed. New York: Marcel Dekker Inc., 1995:91-103.
5. Chu NS, Huang CC, Lu CS, Calne DB. Dystonia caused by toxins. In: Tsui JKC, Clane DB, eds. Handbook of Dystonia, vol 39 1st ed. New York, Basel, Hong Kong: Marcel Dekker Inc., 1995:241-65.
6. Feldman RG. Manganese. Occupational and Environmental Neurotoxicology. 1st ed. New York: Lippincott-Raven Press, 1999:168-88.
7. Saric M. Manganese. In: Friberg I, Nordberg GI, Vouk V, eds. Handbook of Toxicology of Metals. 1st ed. Amsterdam: Elsevier, 1986:354-70.
8. Cersosimo MG, Koller WC. The diagnosis of manganese-induced parkinsonism. NeuroToxicology 2006;27:340-6.
9. Lynam DR, Pfeifer GD, Fort BF, Ter Hear GL, Hollrah DP. Atmosperic exposure to manganese from use of methylcyclopentadienyl manganese tricarbonyl (MMT) performance additive. Sci Total Environ 1994;146:103-9.
10. Cooper WC. The health implications of increased manganese in the environment resulting form the combustion of fuel additives: a review of the literature. J Toxicol Environ Health 1984;14:23-46.
11. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol 1837;1:41-2.
12. Emara AM, El-Ghawabi SH, Madkour OI, El-Samra GH. Chronic manganese poisoning in the dry battery industry. Br J Ind Med 1971;28:78-82.
13. Huang CC, Chu NS, Lu CS, Wang JD, Tsai JL, Wolters EC, Calne DB. Chronic manganese intoxication. Arch Neurol 1989;46:1104-6.
14. Ono K, Komai K, Yamada M. Myoclonic involuntary movement associated with chronic manganese poisoning. J Neurol Sci 2002;199:93-6.
15. Ferraz HB, Bertolucci PHF, Pereria JS, Lima JGC, Andrade LAF. Chronic exposure to the fungicide Maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 1988;38:550-3.
16. Ensing JG. Bazooka: cocaine-base and manganese carbonate. J Anal Toxicol 1985;9:45-6.
17. Lynam DR, Roos JW, Pfeifer GD, Fort BF, Pullin TG. Environmental effects and exposures to manganese from use of methylcyclopentadienyl manganese tricarbonyl (MMT) in gasoline. NeuroToxicology 1999;20:145-50.
18. Hudnell HK. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies. NeuroToxicology 1999;20:379-97.
19. Ejima A, Imamura T, Nakamura S, Saito H, Matsumoto K, Momono S. Manganese intoxication during total parenteral nutrition. Lancet 1992;339:426.
20. Kondakis XG, Makris N, Leotsinidis M, Prinou M, Papapetropoulos T. Possible health effects of high manganese concentration in drinking water. Arch Environ Health 1989;44:175-8.
21. Embden H. Zur Kentniss dre metallischen nervengifte. Deutsch Med Wochenschr 1901;27:795-6.
22. Von Jaksch R. Ueber Mangantoxikosen und manganophobie. Muench Med Wochenschr 1907;20:969-72.
23. Edsall DL, Wilbur FP, Drinker CK. The occurrence, course and prevention of chronic manganese poisoning. Ind Hyg 1919;1:183-93.
24. Rodier J. Manganese poisoning in Moroccan miners. Br J Ind Med 1955;12:21-35.
25. Flinn RH, Neal PA, Fulton WB. Industrial manganese poisoning. J Ind Hyg Toxicol 1941;23:374-87.
26. Smyth LT, Ruhf RC, Whitman NE, Dugan T. Clinical manganism and exposure to manganese in the production and processing of ferromanganese alloy. J Occup Med 1973;15:101-9.
27. Wang D, Zhou W, Wang S, Zheng W. Occupational exposure to manganese in welders and associated neurodegenerative diseases in China. Toxicologist 1998;42:24-30.
28. Sadek AH, Rauch R, Schulz PE. Parkinsonism due to manganism in a welder. Int J Toxicol 2003;22:393-401.
29. Canavan MM, Cobb S, Drinker CK. Chronic manganese poisoning. Psychiatry 1934;32:501-12.
30. Mena I, Marin O, Fuenzalida S, Cotzias GC. Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 1967;17:128-36.
31. Mena I, Court J, Fuenzalida S, Papavasiliou PS, Cotzias GC. Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane. N Engl J Med 1970;282:5-10.
32. Cotzias GC, Horiuchi K, Fuenzalids S, Mena I. Chronic manganese poisoning: clearance of tissue manganese concentrations with persistence of the neurological picture. Neurology 1968;18:376-82.
33. Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 1974;30:59-64.
34. Rosenstock HA, Simons DG, Meyer JS. Chronic manganism: neurologic and laboratory studies during treatment with levodopa. JAMA 1971;217:1354-8.
35. Wang JD, Huang CC, Huang YH, Chiang JR, Lin JM, Chen JS. Manganese induced parkinsonism: an outbreak due to unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med 1989;46:856-9.
36. Huang CC, Chu NS, Lu CS, Calne DB. Cock gait in manganese intoxication. Mov Disord 1997;12:807-8.
37. Huang CC, Lu CS, Chu NS, Hochberg F, Lilienfeld D. Olanow W, Calne DB. Progression after chronic manganese exposure. Neurology 1993;43:1479-83.
38. Huang CC, Chu NS, Lu CS, Chen RS, Calne DB. Long-term progression in chronic manganism: ten years of follow-up. Neurology 1998;50:698-700.
39. Huang CC, Chu NS, Lu CS, Chen RS, Schulzer M, Calne DB. The natural history of neurological manganism over 18 years. Parkinsonism Relat Disord 2007;13:143-5.
40. Lu CS, Huang CC, Chu NS, Calne DB. Levodopa failure in chronic manganism. Neurology 1994;44:1600-2.
41. Crossgroue J, Zheng W. Manganese toxicity upon overexposure. NMR Biomed 2004;17:543-53.
42. Ky S, Deng H, Xie P, Hu W. A report of two cases of chronic serious manganese poisoning treated with sodium para-aminosalicylic acid. Br J Ind Med 1992;49:66-9.
43. Bowler RM, Mergler D, Sassine MP, Larribe F, Hudnell K. Neuropsychiatric effects of manganese on mood. NeuroToxicology 1999;20:367-78.
44. Pettersen R, Ellingsen DG, Hetland SM, Thomassenn Y. Neuropsychological function in manganese alloy plant workers. Int Arch Occup Environ Health 2004;77:277-87.
45. Bowler RM, Gysens S, Diamond E, Booty A, Hartney C, Roels HA. Neuropsychological sequelae of exposure to welding fumes in a group of occupationally exposed men. Int J Hyg Environ Health 2003;206:517-29.
46. Hua MS, Huang CC. Chronic occupational exposure to manganese and neurobehavioral function. J Clin Exp Neuropsychol 1991;13:497-507.
47. Chu NS, Hung CC, Calne DB. Sympathetic skin response and RR interval variation in manganism and a comparison with Parkinson's disease. Parkinsonism Relat Disord 1996;2:23-8.
48. Newland MC, Ceckler TL, Kordower JH, Weiss B. Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp Neurol 1989;106:251-8.
49. Nelson K, Golnick J, Korn T, Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med 1993;50:510-3.
50. Josephs KA, Ahlskog E, Klos KJ, Kumar N, Fealey RD, Trenerry MR, Cowl CT. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 2005;64:2033-9.
51. Kim Y, Kim KS, Yang JS, Park IJ, Kim E, Jin Y, Kwon KR, Chang KH, Kim JW, Park SH, Lim HS, Cheong HK, Shin YC, Park J, Moon Y. Increase in signal intensities on T1-weighted magnetic resonance images in asymptomatic manganese-exposed workers. NeuroToxicology 1999;20:901-8.
52. Kim Y. Neuroimaging in manganism. NeuroToxicology 2006;27:369-72.
53. Hauser RA, Zesiewicz TA, Rosemurgy AS, Martinez C, Olanow CW. Manganese intoxication and chronic liver failure. Ann Neurol 1994;36:871-5.
54. Hauser RA, Zesiewicz TA, Martinez C, Rosemurgy AS, Olanow CW. Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can J Neurol Sci 1996;23:95-8.
55. Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 1995;346:270-4.
56. Kim Y, Kim JW, Ito K, Lim HS, Cheong HK, Kim JY, Shin YC, Kim KS, Moon Y. Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. NeuroToxicology 1999;20:249-52.
57. Kim E, Kim Y, Cheong HK, Cho S, Shin YC, Sakong J, Kim KS, Yang JS, Jin YW, Kang SK. Pallidal index on MRI as a target organ dose of manganese: structural equation model analysis. NeuroToxicology 2005;26:351-9.
58. 18F] dopa PET findings in early Parkinson's disease. J Neurol Neurosurg Psychiatry 1995;59:597-600.
59. Calne DB, Langston JW. Etiology of Parkinson's disease. Lancet 1983;2:1457-9.
60. 18F] fluorodopa studies correlate with dopamine cell counts and levels. Ann Neurol 1993;34:324-30.
61. Wolters E, Huang CC, Clark C, Peppard RF, Okada J, Chu NS, Adam MJ, Ruth TJ, Li D, Calne DB. Positron emission tomography in manganese intoxication. Ann Neurol 1989;26:647-51.
62. 11C-raclopride and positron emission tomography. Ann Neurol 1992;31:184-92.
63. Rinne UK, Laihinen A, Rinne JO, Nagren K, Bergman J, Ruotsalainen V. Positron emission tomography demonstrates dopamine D2-receptor supersenitivity in the striatum of patients with early Parkinson's disease. Mov Disord 1990;5:55-9.
64. Shinotoh H, Snow BJ, Chu NS, Huang CC, Lu CS, Lee C, Takahashi H, Calne DB. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study. Neurology 1997;48:1053-6.
65. Huang CC, Yen TC, Weng YH, Lu CS. Normal dopamine transporter binding in dopa responsive dystonia. J Neurol 2002;249:1016-20.
66. 99m Tc-TRODAT-1. Eur J Nucl Med 1996;23:1527-30.
67. 123I]- β-CIT single photon emission computed tomography is normal in dopa-responsive dystonia. Ann Neurol 1998;43:782-800.
68. 18F] CFT. Ann Neurol 2000;47:804-8.
69. 99mTc] TRODAT-1 as dopamine transporter imaging agents. J Nucl Med 1998;41:428-36.
70. 99mTc]-TRODAT-1 to dopamine transporter in patients with Parkinson's disease and in healthy volunteers. J Nucl Med 2000;41:584-9.
71. Huang CC, Weng YH, Lu CS, Chu NS, Yen TC. Dopamine transporter binding in chronic manganese intoxication. J Neurol 2003;250:1335-9.
72. Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H, Ushio K, Tsukagoshi H. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol (Berlin) 1986;70:273-8.
73. Neff NH, Barrett RE, Costa E. Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys. Experientia 1969;25:1140-1.
74. Brouillet EP, Shinobu L, McGarvey U, Hochberg F, Beal MF. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp Neurol 1993;120:89-94.
75. Newland M, Cox C, Hamada R. The clearance of manganese chloride in the primate. Fundam App Toxicol 1987;9:314-28.
76. Spadoni F, Stefani A, Morello M, Lavaroni F, Giacomini P, Sancesario G. Selective vulnerability of pallidal neurons in the early phases of manganese intoxication. Exp Brain Res 2000;135:544-51.
77. Olanow CW, Good PF, Shinotoh H, Hewitt KA, Vingerhoets F, Snow BJ, Beal MF, Calne DB, Perl DP. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 1996;46:492-8.
78. Pal PK, Samii A, Calne DB. Manganese neurotoxicity: a review of clinical features, imaging and pathology. NeuroToxicology 1999;20:227-38.
79. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994;44:1583-6.
80. Olanow CW. Manganese-induced parkinsonism and Parkinson's disease. Ann NY Acad Sci 2004;1012:209-23.
81. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology 2005;64:2021-8.
82. Lee CS, Schulzer M, Mak EK, Snow BJ, Taui JK, Calne S, Calne DB. Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 1994;117:501-7.
83. Lee CS, Schulzer M, Mak EK, Hammerstad JP, Calne S, Calne DB. Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implication for pathogenesis. Neurology 1995;45:435-9.
84. Abd-El Naby S, Hassanein M. Neuropsychiatric manifestation of chronic manganese poisoning. J Neurol Neurosurg Psychiatry 1965;28:282-8.
85. Bowler RM, Koller W, Schulz PE. Parkinsonism due to manganism in a welder: Neurological and neuropsychological sequelae. NeuroToxicology 2006;27:327-32.
86. Kaiser J. State court to rule on manganese fume claims. Science 2003;300:927.
87. Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 2001;56:8-13.
88. 18F] FDOPA PET and clinical features in parkinsonism due to manganism. Mov Disord 2005;20:492-6.
89. Racette BA, Tabbal SD, Jennings D, Good L, Perlmutter JS, Evanoff B. Prevalence of parkinsonism and relation-ship to exposure in a large sample of Alabama welders. Neurology 2005;64:230-5.